VENUS REMEDIES LTD. - 526953 - Closure of Trading Window
Pursuant to the Code of Conduct adopted by the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015, this is to inform that the trading window for dealing in equity shares of the Company shall remain closed for all Designated Persons of the Company, as defined under the said Regulations, from July 1, 2022 till 48 hours from the declaration of the Unaudited Financial Results for the Quarter ending June 30, 2022. VENUS REMEDIES LTD. - 526953 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation for issue of Duplicate Share Certificate. VENUS REMEDIES LTD. - 526953 - Disclosure Of Related Party Transaction Pursuant To Regulation 23(9) Of The SEBI (Listing Obligations & Disclosures Requirements) Regulations, 2015
Disclosure of Related Party Transaction pursuant to Regulation 23(9) of the SEBI (Listing Obligations & Disclosures Requirements) Regulations, 2015 VENUS REMEDIES LTD. - 526953 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Stop Transfer Intimation pursuant to Regulation39(3) of the SEBI (LODR). VENUS REMEDIES LTD. - 526953 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pawan Chaudhary VENUS REMEDIES LTD. - 526953 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pawan Chaudhary VENUS REMEDIES LTD. - 526953 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed herewith newspaper publication of Financial Results as on 31st March 2022.
Venus Remedies registers 9.22% growth in sales for FY 2021-22
The Panchkula-based company also reported a 16.81 per cent increase in operating profit, which went up from Rs 53.78 crore last fiscal to Rs 62.82 crore in 2021-22. VENUS REMEDIES LTD. - 526953 - Announcement under Regulation 30 (LODR)-Change in Management
As per the attachment. VENUS REMEDIES LTD. - 526953 - Financial Results For The Quarter And Year Ended On 31St March 2022.
Financial Results for the quarter and year ended on 31st March 2022.